Among patients with eGFR < 60 mL/min/1.73m2, we observed higher Ang-2 plasma levels (11,573 ± 9,441 pg/mL, n = 5 vs. 4,652 ± 7,415 pg/mL, n = 21; p = 0.021) and sTM plasma levels (11,641 ± 3,795 pg/mL, n = 5 vs. 7,032 ± 2,147 ng/mL, n = 2; p = 0.008) in patients with AKI than in patients without AKI (Figure 1). This evidence concerns the gene ANGPT2 and acute kidney injury.